News and Events

US Patent, Conference Presentations Herald Further Progress for Hatchtech

25/07/2012 | Press Releases

Hatchtech Pty Ltd has been advised the United States Patent and Trademark Office has granted a patent covering a key element of the Company’s novel head lice treatment product, DeOvo™.  In further progress, the Company’s Chief Scientific Officer Dr Vern Bowles has presented data from Hatchtech’s highly successful Phase 2b clinical trial at the recent 38th Annual Meeting of the Society for Pediatric Dermatology in the United States.

Download PDF